ECP 2018 Final Programme

Sunday, 9 Sept 78 ECP 2018 · Bilbao Poster Presentations a Sunday PS-01 040 Tumour-infiltrating lymphocytes (TILs) as a predictor of response to neadjuvant chemotherapy in breast cancer Laura Hernandez Leon, Spain G. Tapia Melendo, E. Castellà Fernández, T. V. Sanhueza, R. Marginet Flinch, M. Martín Céspedes, V. Quiroga García, M. Margelí Vila 041 Lymphoepithelioma-like breast carci- noma. Report of a case Eleni Pigadioti, Greece N. Koufopoulos, D. Dimas, E. Kanari, I. Missitzis, L. Khaldi 042 The diagnostic value of liquid-based cytology in thyroid fine needle aspiration: an institutional experience Canan Sadullahoglu, Turkey H. Tosun Yildirim, S. Yildirim, I. Atalay Karacay, D. Nergiz, A. Sezgin Alikanoglu, D. Süren, C. Sezer 043 Acinic cell carcinoma of the breast associated with high grade ductal carcinoma: a case report Justino Jiménez Almonacid, Spain J. L. García Pérez, M. d. la Paloma Arribas Granado, M. Blanco Bellas, L. Hernández Sánchez 045 Primary mucinous cystadenocarcinoma of the breast: report of a rare case Elli Botsfari, Greece N. Vladika, S. Barbanis, D. Gerasimidou, B. Christoforidou, E. Triantafillidou, R. Iosiphidou, P. Xirou 046 Comparison of immunohistochemical markers before and after neoadjuvant chemotherapy in breast cancer and their use as predictor od response Irena Jovanic, Serbia Z. Milovanovic, O. Zivkovic, N. Medic Milijic 047 Prolactin and circulating vitamin D levels as risk factors for benign breast tumour Elena Valeeva, Russia I. Garifullova, O. Kravtsova, N. Akberova, L. Maltseva 033 Sentinel lymph node biopsy (SLNB) versus axillary lymph node dissection (ALND) following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis: retrospective study Mariagrazia Cattani, Italy S. Calderoni, M. C. Cucchi, M. P. Foschini 034 Primary breast lymphoma. Presentation of eight cases with literature review Olympia Tzaida, Greece M. Kotsopoulou, N. Novkovic, G. Stanc, P. Lampropoulou, P. Repousis, A. Megalakaki, I. Nomikos 035 The value of tumour infiltrating lympho- cytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a study in a hospital complex Alicia Cordoba, Spain Y. Ruiz de Azúa, C. Arean, B. Aguiar, L. Nova, T. Labiano, A. Ulazia, D. Guerrero 036 Discrepancy in hormones and growth factor receptor expression in primary versus metastatic breast cancer Maia Mchedlishvili, Georgia N. Kekelidze, N. Chikhladze, K. Khachapuridze, K. Tsomaia 037 ALDH1L1 downregulation and hyper- methylation in breast cancer Roman Novakovskiy, Russia G. Puzanov, N. Melnikova, A. Dmitriev, A. Beniaminov 038 Hormone receptor status in invasive breast carcinoma – single institution results of more than 10,000 consecutive cases Primoz Drev, Slovenia O. Blatnik, J. Blazina, J. Contreras, G. Gašljevic, M. Gjidera, B. Grcar Kuzmanov, A. Klevišar Ivancic, S. Djokic, B. Gazic 039 Adenomyoepithelioma and malignancy in association with adenomyoepithelioma, 4 cases from a single center Taha Cumhan Savli, Turkey E. C. Kelten Talu, D. Can Trabulus, U. Gursu